The Drug Policy Alliance convenes the Reform Conference every two years, to bring together drug policy reformers from across the United States and around the world.
The International Harm Reduction Development Program of the Open Society Institute will fund scholarships in order to support the participation of our international partners.
The conference will include plenaries, panel discussions, roundtables, and training sessions on such topics as advocacy; harm reduction; foreign and international drug policies; prohibition, decriminalization, and legalization; medical marijuana; and sentencing reform. Conference attendees comprise federal, state, and local elected officials, health care professionals, public health administrators, drug counselors, people in recovery as well as active drug users, criminal justice advocates, law enforcement officers, students, educators, and grassroots activists.
For more information, to submit proposals, and to register for the conference, please visit the conference website at www.reformconference.org/.
Read more
Voices
License to Deceive? A Big Drug Company’s Smokescreen on Hepatitis C
What’s really driving the pharmaceutical giant Gilead to issue a license for generic copies of its superstar drug? Profit.
Voices
No Documents, No Doctor? No Longer
Jamila used to be one of many people in Kyrgyzstan denied health care because she did not have a permanent address. Now, thanks to work by Asteria, she’s looking forward to her first doctor’s appointment.
Voices
Following the Money in Asian Drug War Abuses, and Finding U.S. Aid
The United States should take a hard look at how its foreign aid is being used to support detention centers where people suspected of using drugs are detained, beaten, and humiliated in the name of public health.